Adjusted EBITDA for fiscal Q3 set a record and beat analyst expectations
Company attributes results to operating leverage and growth in Canada and Germany
Analyst coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the drug retailers peer group is "buy"
Wall Street's median 12-month price target for High Tide Inc is C$7.00, about 100.6% above its September 11 closing price of C$3.49
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 25 three months ago
HITI•
